This study is being done to find the best dose of an investigational drug called NBM-BMX for people with metastatic uveal melanoma, a type of eye cancer that h…

Metastatic Uveal MelanomaUveal Melanoma, MetastaticUveal Melanoma, Recurrent+2 more

~Estimated

~$150 – $4,200

Actual pay is set by the research site.

Novelwise Pharmaceutical CorporationNCT07136181

Phase 2

Low-Dose Dexamethasone Premedication for the Prevention of Cytokine Release Syndrome Associated With Tebentafusp in Advanced Uveal Melanoma

The goal of this clinical trial is to learn if a low dose of dexamethasone can prevent cytokine release syndrome in participants treated with tebentafusp for a…

Uveal Melanoma, Metastatic

~Estimated

~$75 – $2,000

Actual pay is set by the research site.

University of California, San DiegoNCT07803562